Medical Graphics, a US company involved in non-invasive cardiorespiratory diagnostic systems, has announced several management changes as part of its expansion into new and related markets. Chris Hutchinson, former vice-president of marketing with McGaw, is named vice-president of sales and marketing. Terry Kapsen is promoted from the sales team to vice-president of medical and clinical affairs. Roger Jacobi, previously executive director of marketing, is also promoted to vice-president of the company's asthma business.
PEOPLE - Medical Graphics makes appointments:
Medical Graphics, a US company involved in non-invasive cardiorespiratory diagnostic systems, has announced several management changes as part of its expansion into new and related markets. Chris Hutchinson, former vice-president of marketing with McGaw, is named vice-president of sales and marketing. Terry Kapsen is promoted from the sales team to vice-president of medical and clinical affairs. Roger Jacobi, previously executive director of marketing, is also promoted to vice-president of the company's asthma business.
More from Archive
• By
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
• By
Editor’s note: We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, content format or the method in which you receive and access Medtech Insight, or if you love it how it is, now is the time to have your voice heard.
• By
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
• By
In this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement andcompliance with the US FDA Lab Developed Test ruling.
More from Medtech Insight
• By
Announced after three years of negotiation, the FTA eliminates tariffs on 99% of Indian product types, covering nearly all trade value, and reduces tariffs on 90% of UK products. Although not yet formally signed, the deal is being positioned by the Indian government as “transformative,” with an estimated economic impact of $6.4bn for the UK alone by 2040.
• By
Medtronic’s diabetes spin-out – a process likely to run up to 18 months and involve 20% IPO followed by a split-off for Medtronic shareholders – will allow firm to focus on higher-margin devices.
• By
Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.